Sean Hawkey Photography

  • About
  • Contact
  • Photo Library
    • All Galleries
    • Search
    • Cart
    • Lightbox
    • Client Area
  • Video
  • Facebook
  • Twitter
x

Search Results

Refine Search
Match all words
Match any word
Prints
Personal Use
Royalty-Free
Rights-Managed
(leave unchecked to
search all images)
32 images found
twitterlinkedinfacebook

Loading ()...

  • Mohamed Soumah, 27, the first person to be vaccinated in the Ebola vaccine trial. "It wasn't easy, I can't say I wasn't afraid, I was afraid. People in the village were saying that the injection was to kill me. I was the first one to be injected, the very first, here in my village on March 23. 44 people were vaccinated. I had fever after the vaccination, it worried me a bit, but they warned me that would happen and it didn't last long. I've been monitored for three months and I've had no problems. The last follow up, 84 days after the vaccination, was all clear".
    Guinea_Hawkey_ebola_20150702_0207.jpg
  • A doctor wore PPE in the phase III clinical trials for Ebola virus disease vaccine in Guinea. The technique used was "ring vaccination" which was used in the 1970s to eliminate smallpox.
    Guinea_Hawkey_ebola_20150630_1639.jpg
  • The World Health Organisation is running phase III clinical trials for ebola virus disease vaccine in Guinea. The technique being used is "ring vaccination" which was used in the 1970s to eliminate smallpox.
    Guinea_Hawkey_ebola_20150630_1592.jpg
  • Karamoko Sonah Camara, head of a WHO Ebola vaccination trial team, prepared pharmaceuticals for the participants of the trial.
    Guinea_Hawkey_ebola_20150630_1958.jpg
  • While the Ebola vaccine was trialled it had to be kept at a temperature of minus 60 degrees celsius, these Arktek passive vaccine storage devices use jet fuel to keep the right temperature for up to five days in the field, even being opened several times a day. Here a vaccine core is being inserted into the device.
    Guinea_Hawkey_ebola_20150629_0252.jpg
  • Hadja Kakoro Sogbe and Halimatu Diallo, members of team nine of the WHO Ebola vaccine trials in Guinea, went through the extensive consent procedure with a participant in the Ebola vaccine trial. They wore protective clothing as the participants were all direct contacts of verified cases of Ebola.
    Guinea_Hawkey_ebola_20150630_1635.jpg
  • The phase III clinical trial of the Ebola vaccine in Guinea was hampered by difficulty in transport to remote regions.
    Guinea_Hawkey_ebola_20150702_0142.jpg
  • The bonnet of a vehicle of the World Health Organisation during the clinical trials for ebola virus disease vaccine in Guinea.
    Guinea_Hawkey_ebola_20150704_1600.jpg
  • The phase III clinical trial of the Ebola vaccine in Guinea was hampered by difficulty in transport to remote regions.
    Guinea_Hawkey_ebola_20150702_0146.jpg
  • A young man in Bonfe village, the first village in Guinea to take part in the Ebola vaccine trials that begin in March 2015.
    Guinea_Hawkey_ebola_20150702_0183.jpg
  • rVSV Zebov-GP, the Ebola vaccine that was trialled in Guinea, ready to be administered to a participant in the clinical trial in Guinea.
    Guinea_Hawkey_ebola_20150630_2102.jpg
  • A young woman in the village of Katongourou, western Guinea, an area heavily affected by Ebola. Many people in the village were participants in the WHO Ebola vaccine trial.
    Guinea_Hawkey_ebola_20150630_1844.jpg
  • rVSV Zebov-GP, the Ebola vaccine that was trialled in Guinea, ready to be administered to a participant in the clinical trial in Guinea.
    Guinea_Hawkey_ebola_20150630_1745.jpg
  • Billo Mamadou Diallo, Karamoko Sonah Camara, Alain Mukendi, Jean Francoi Tolno and Hawa Madi, part of Team Nine of the WHO Ebola vaccine trial staff, at work in Katongourou, Guinea .
    Guinea_Hawkey_ebola_20150630_1661.jpg
  • Mamadouba Conté processed blood samples in the Ebola lab at Donka Hospital in Conakry, Guinea as part of the Ebola vaccine clinical trials.
    Guinea_Hawkey_ebola_20150629_0389.jpg
  • WHO staff prepared pharmaceuticals for participants in the clinical trials of the Ebola vaccine in Guinea.
    Guinea_Hawkey_ebola_20150629_0304.jpg
  • Foromo Kpakpavogui, Ebola vaccine laboratory technician at Donka Hospital, Conakry, Guinea.
    Guinea_Hawkey_ebola_20150629_0191.jpg
  • Fatoumata Conte, logisitics specialist for the WHO during the Ebola vaccine clinical trial in Conakry, Guinea.
    Guinea_Hawkey_ebola_20150703_0002.jpg
  • rVSV Zebov-GP, the Ebola vaccine being prepared for injection.
    Guinea_Hawkey_ebola_20150630_2116.jpg
  • Team nine of the WHO Ebola vaccine trial at work in Guinea.
    Guinea_Hawkey_ebola_20150630_2019.jpg
  • Nene Aminata Diallo (l) and Gamou Saiman Gaston (r), carefully go through the consent process with a participant in the Ebola vaccine trial.
    Guinea_Hawkey_ebola_20150630_1954.jpg
  • Young men in Bonfe village, the first village in Guinea to take part in the Ebola vaccine trials that began in March 2015.
    Guinea_Hawkey_ebola_20150702_0017.jpg
  • During the phase III Ebola vaccine trial in Guinea, serum was separated from red blood cells for Ebola tests in Donka Hospital in Conakry, Guinea.
    Guinea_Hawkey_ebola_20150629_0134.jpg
  • Dr. Sakoba Keita, coordinator of the Guinean Ebola Response spoke to local media during a village meeting on Ebola.
    Guinea_Hawkey_ebola_20150704_1689.jpg
  • A security guard in Guinea wears PPE and holds a thermo flash, a non-contact thermometer for testing at a road block. High temperature is the first major sign of Ebola infection, anyone with a temperature of 37 degrees celsius or above was stopped immediately for further testing and isolation to stop the spread of infections.
    Guinea_Hawkey_ebola_20150630_1848.jpg
  • Dr. Sakoba Keita, coordinator of the Guinean Ebola Response spoke to local media during a village meeting on Ebola.
    Guinea_Hawkey_ebola_20150704_1800.jpg
  • Allasane Coumbassa, at the Conakry City Morgue. The morgue dealt with many Ebola deaths, Ousmane complained of inadequate protective measures, clothing or waste management to deal with the Ebola .
    Guinea_Hawkey_ebola_20150703_0025.jpg
  • A poster from the Ebola ça Suffit campaign against Ebola in Guinea
    Guinea_Hawkey_ebola_20150630_2082.jpg
  • A security guard in Guinea wears PPE and holds a thermo flash, a non-contact thermometer for testing at a road block. High temperature is the first major sign of Ebola infection, anyone with a temperature of 37 degrees celsius or above was stopped immediately for further testing and isolation to stop the spread of infections.
    Guinea_Hawkey_ebola_20150630_2050.jpg
  • The drill for destroying the Ebola virus where medical staff come in contact with confirmed cases is strict routine, one small mistake and the infection can be passed on. Staff in PPE, are often close to being overcome by the heat and dehydration, and sometimes need to be shouted instructions like "raise your head up" as each part of the drill is gone through, a series of specific movements as they are sprayed with a bleach solution and each part of the protective clothing is peeled off in the right order and in the right direction, and put straight in the incineration bucket, even the ground where they stand is considered contaminated and has to be covered in bleach. Eventually, a very grateful and completely sweat-sodden worker emerges from inside.
    Guinea_Hawkey_ebola_20150630_2093.jpg
  • Aboubacar Sylla, aged 79, lost 4 members of his family in the Ebola outbreak of 2014-15. <br />
<br />
His daughter M’Mah was one of the lucky ones. As soon as she started showing symptoms of the deadly disease, her father made sure that she was taken straight to hospital where early treatment helped save her life. <br />
<br />
Surrounded by multiple generations of his large family at their home in the district of Dixinn Port, Conakry, Sylla tells how the family was shunned by their own community when Ebola struck his family.<br />
<br />
“Before the Ebola outbreak, everyone talked to one another here. Then suddenly we weren’t even allowed to leave our house,” he said.<br />
<br />
People stopped using the well in the open area in front of their home for fear of contamination and the children were forbidden to step out past the boundary of their front courtyard where they were used to playing.<br />
<br />
M’Mah was not living in the family house when she got sick, but her brother Aboubacar was the one who went to her house where she was living with her husband and took her to the Ebola treatment centre in Nongo. <br />
<br />
“Everyone was so scared of Ebola but I couldn’t just abandon my sister. She would have died,” he said, telling how his decision to ride in the ambulance with her caused division within the family.<br />
Since then, even though he never got sick, Aboubacar has suffered stigma from his contact with Ebola and has found it difficult to get work anymore. <br />
<br />
As soon as M’Mah arrived at the Ebola treatment centre, the disease surveillance system alerted the vaccine trial team of this new case. The team sent two local social mobilizers, trained specifically by WHO for this delicate role, to visit the family and to ask if they would agree to participate in a research trial to help develop a vaccine against Ebola. <br />
The Guinea vaccine trial, led by WHO, used a method called ring vaccination. This method, used to eradicate smallpox, aims to vaccinate a “ring” of all the people who had close contact with the pe
    Guinea_Hawkey_Ebola_WHO_20170503_133.jpg
  • Aboubacar Sylla, aged 79, lost 4 members of his family in the Ebola outbreak of 2014-15. <br />
<br />
His daughter M’Mah was one of the lucky ones. As soon as she started showing symptoms of the deadly disease, her father made sure that she was taken straight to hospital where early treatment helped save her life. <br />
<br />
Surrounded by multiple generations of his large family at their home in the district of Dixinn Port, Conakry, Sylla tells how the family was shunned by their own community when Ebola struck his family.<br />
<br />
“Before the Ebola outbreak, everyone talked to one another here. Then suddenly we weren’t even allowed to leave our house,” he said.<br />
<br />
People stopped using the well in the open area in front of their home for fear of contamination and the children were forbidden to step out past the boundary of their front courtyard where they were used to playing.<br />
<br />
M’Mah was not living in the family house when she got sick, but her brother Aboubacar was the one who went to her house where she was living with her husband and took her to the Ebola treatment centre in Nongo. <br />
<br />
“Everyone was so scared of Ebola but I couldn’t just abandon my sister. She would have died,” he said, telling how his decision to ride in the ambulance with her caused division within the family.<br />
<br />
Since then, even though he never got sick, Aboubacar has suffered stigma from his contact with Ebola and has found it difficult to get work anymore. <br />
<br />
As soon as M’Mah arrived at the Ebola treatment centre, the disease surveillance system alerted the vaccine trial team of this new case. The team sent two local social mobilizers, trained specifically by WHO for this delicate role, to visit the family and to ask if they would agree to participate in a research trial to help develop a vaccine against Ebola. <br />
The Guinea vaccine trial, led by WHO, used a method called ring vaccination. This method, used to eradicate smallpox, aims to vaccinate a “ring” of all the people who had close contact with the p
    Guinea_Hawkey_Ebola_WHO_20170503_123.jpg